A detailed history of Black Rock Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,192,627 shares of RCKT stock, worth $71.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,192,627
Previous 5,929,910 4.43%
Holding current value
$71.6 Million
Previous $160 Million 16.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$20.66 - $26.72 $5.43 Million - $7.02 Million
262,717 Added 4.43%
6,192,627 $133 Million
Q1 2024

May 10, 2024

SELL
$26.16 - $30.74 $7,010 - $8,238
-268 Reduced -0.0%
5,929,910 $160 Million
Q4 2023

Feb 13, 2024

BUY
$16.78 - $31.94 $13.7 Million - $26.1 Million
816,551 Added 15.97%
5,930,178 $178 Million
Q3 2023

Nov 13, 2023

SELL
$15.07 - $24.05 $334,252 - $533,429
-22,180 Reduced 0.43%
5,113,627 $105 Million
Q2 2023

Aug 11, 2023

SELL
$16.59 - $23.6 $5.49 Million - $7.82 Million
-331,163 Reduced 6.06%
5,135,807 $102 Million
Q1 2023

May 12, 2023

SELL
$15.79 - $22.6 $1.9 Million - $2.72 Million
-120,565 Reduced 2.16%
5,466,970 $93.6 Million
Q4 2022

Feb 13, 2023

BUY
$15.5 - $22.76 $16.9 Million - $24.9 Million
1,093,261 Added 24.33%
5,587,535 $109 Million
Q3 2022

Nov 14, 2022

BUY
$12.37 - $18.41 $6.04 Million - $8.99 Million
488,509 Added 12.2%
4,494,274 $71.7 Million
Q2 2022

Aug 12, 2022

BUY
$7.96 - $16.64 $5.37 Million - $11.2 Million
674,397 Added 20.24%
4,005,765 $55.1 Million
Q1 2022

May 12, 2022

SELL
$13.16 - $23.68 $106,609 - $191,831
-8,101 Reduced 0.24%
3,331,368 $52.8 Million
Q4 2021

Feb 10, 2022

BUY
$21.52 - $36.02 $2.6 Million - $4.36 Million
120,978 Added 3.76%
3,339,469 $72.9 Million
Q3 2021

Nov 09, 2021

BUY
$27.42 - $48.97 $1.33 Million - $2.37 Million
48,359 Added 1.53%
3,218,491 $96.2 Million
Q2 2021

Aug 11, 2021

BUY
$39.41 - $47.25 $125 Million - $150 Million
3,170,132 New
3,170,132 $140 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $875M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.